ArticleBMC infectious diseases2021

Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda.

Adelline Twimukye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.